Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
EPCAM encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. Additionally we are shipping EPCAM Proteins (46) and EPCAM Kits (39) and many more products for this protein.
Showing 10 out of 1035 products:
Human Monoclonal EPCAM Primary Antibody for IHC (fro), IF - ABIN111179
Balzar, Winter, de Boer, Litvinov: The biology of the 17-1A antigen (Ep-CAM). in Journal of molecular medicine (Berlin, Germany) 2000
Show all 11 references for 111179
Human Monoclonal EPCAM Primary Antibody for IHC (fro), IHC (p) - ABIN111178
Joplin, Strain, Neuberger: Immuno-isolation and culture of biliary epithelial cells from normal human liver. in In vitro cellular & developmental biology : journal of the Tissue Culture Association 1990
Show all 9 references for 111178
Human Monoclonal EPCAM Primary Antibody for CyTOF, ELISA - ABIN153141
Jordinson, El-Hariry, Calnan, Calam, Pignatelli: Vicia faba agglutinin, the lectin present in broad beans, stimulates differentiation of undifferentiated colon cancer cells. in Gut 1999
Show all 8 references for 153141
Human Monoclonal EPCAM Primary Antibody for FACS, IF - ABIN614761
Edwards, Grzyb, Dressler, Mansel, Zava, Sledge, McGuire: Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. in Cancer research 1986
Show all 7 references for 614761
Human Monoclonal EPCAM Primary Antibody for ELISA (Capture), FACS - ABIN4900527
Seeber, Martowicz, Spizzo, Buratti, Obrist, Fong, Gastl, Untergasser: Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro. in BMC cancer 2015
Show all 4 references for 4900527
Human Monoclonal EPCAM Primary Antibody for FACS - ABIN4897896
Lotti, Jarrar, Pai, Hitomi, Lathia, Mace, Gantt, Sukhdeo, DeVecchio, Vasanji, Leahy, Hjelmeland, Kalady, Rich: Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. in The Journal of experimental medicine 2013
Show all 2 references for 4897896
Human Monoclonal EPCAM Primary Antibody for IHC (p) - ABIN180642
Epenetos, Canti, Taylor-Papadimitriou, Curling, Bodmer: Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions. in Lancet 1982
Show all 2 references for 180642
Mouse (Murine) Monoclonal EPCAM Primary Antibody for IHC (fro), IP - ABIN1042592
Farr, Nelson, Truex, Hosier: Epithelial heterogeneity in the murine thymus: a cell surface glycoprotein expressed by subcapsular and medullary epithelium. in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1991
Human Polyclonal EPCAM Primary Antibody for ELISA, WB - ABIN1997267
Trzpis, Bremer, McLaughlin, de Leij, Harmsen: EpCAM in morphogenesis. in Frontiers in bioscience : a journal and virtual library 2008
Human Monoclonal EPCAM Primary Antibody for FACS - ABIN4897894
Levings, McGarry, Currie, Nickerson, McClellan, Ghivizzani, Steindler, Gibbs: Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma. in Cancer research 2009
Gene ontology analysis revealed that EpCAM controls various developmental programs, including uretric bud development, morphogenesis of branching epithelium, regulation of cell differentiation and cilium morphogenesis.
EpCAM acts as a partner of E-cadherin (show CDH1 Antibodies) to control adhesiveness and integrity as well as plasticity and morphogenesis within simple epithelia
identification of EpCAM in a gain-of-function screen for inducers of abnormal tissue mixing during gastrulation
used a next generation sequencing (NGS) approach. NY-SAR-35 expression induced growth, proliferation, metastasis, and stemness genes, as indicated by the up-regulations of CXCR4 (show CXCR4 Antibodies), EpCAM, CD133, and CD44 (show CD44 Antibodies), at the mRNA and protein levels
These results indicate that adipocyte-secreted factors might regulate cancer stem cell behavior through several signaling molecules including c-Met, STAT3 (show STAT3 Antibodies) and ERK1/2 (show MAPK1/3 Antibodies) and inhibition of these signaling pathways offer novel strategies in targeting the effect of adipose-derived cytokines in cancer.
The meta-analysis demonstrated that the expression of EpCAM in the gastric cancer group was greater than that in the control group. Moreover, EpCAM overexpression was associated with larger tumour size, lymphnode metastasis and worse prognosis in gastric cancer. [review]
expression of EpCAM(MT) is associated with a more aggressive phenotype and predicts poor survival in patients with colorectal cancer.
Higher levels of epithelial cell adhesion molecule (EpCAM) in breast cancer may be associated with poor response to Neoadjuvant chemotherapy (NAC (show NLRP1 Antibodies)) via a potential chemoresistant effect.
By monitoring the change of fluorescence signal, the target EpCAM protein could be detected sensitively and selectively with a linear detection range from 3nM to 54nM and limit of detection (LOD) around 450pM. In addition, this nanobiosensor has been successfully used for EpCAM-expressed breast cancer MCF-7 cell detection
EpCAM, CD44 and CD133 expression could be candidate markers for Barrett esophagus disease progression
These findings are important for a better understanding of epithelial cell adhesion molecule apoptosis regulation and suggest epithelial cell adhesion molecule as a potential target for the treatment of breast cancer.
that epithelial cell adhesion molecule showed different expression pattern among salivary gland neoplasms and in different grades of mucoepidermoid carcinomas
we concluded that the peptide could be a better supplement to the EpCAM antibody for capturing Circulating tumor cells (CTCs) in microfluidic system with broader spectrum
EpCAM appears to differentially regulate Langerhans cell mobility/migration in the setting of limited inflammation as compared with the intense inflammation triggered by contact sensitizers
Knock-down EpCAM cell model of congenital tufting enteropathy was developed. In vivo inducible mouse model was developed resulting in mutant EpCAM protein.
in addition to converting to cholangiocyte-like cells, Sox9 (show SOX9 Antibodies)(+)EpCAM(-) cells provide luminal space near expanded ductular structures to prevent deterioration of the injuries and potentially supply new hepatocytes to repair damaged tissues
EpCAM is a highly conserved protein present in fishes, amphibians, reptiles, birds, marsupials, and placental mammals, and is subject to shedding, gamma-secretase-dependent regulated intramembrane proteolysis, and proteasome-mediated degradation.
Suggest pivotal role of EpCAM in intestinal epithelial structure and integrity, with mutations resulting in congenital tufting enteropathy.
mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin (show CDH1 Antibodies)/beta-catenin (show CTNNB1 Antibodies).
EpCAM contributes to formation of intestinal barrier by recruiting claudins to cell-cell junctions.
These results conclusively link EpCAM expression to Langerhan cell (LC) motility/migration and LC migration to immune regulation.
Results show that SSCs are the most concentrated in CD9 (show CD9 Antibodies)(+)EPCAM(low/-) population and also suggest that EPCAM plays an important role in progenitor cell amplification in the mouse spermatogenic system.
EpCAM could contribute substantially to the pathogenesis of lung cancer.
Ep-CAM may act as a physical homophilic interaction molecule between IELs and IECs at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection [Ep-CAM]
This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and functions as a homotypic calcium-independent cell adhesion molecule. The antigen is being used as a target for immunotherapy treatment of human carcinomas. Mutations in this gene result in congenital tufting enteropathy.
, tumor-associated calcium signal transducer
, epithelial cell adhesion molecule
, tumor-associated calcium signal transducer 1
, CD7 antigen (p41)
, T-cell antigen CD7
, T-cell leukemia antigen
, T-cell surface antigen Leu-9
, p41 protein
, adenocarcinoma-associated antigen
, cell surface glycoprotein Trop-1
, epithelial glycoprotein 314
, human epithelial glycoprotein-2
, major gastrointestinal tumor-associated protein GA733-2
, membrane component, chromosome 4, surface marker (35kD glycoprotein)
, Trop-1 protein
, lymphocyte antigen 74
, panepithelial glycoprotein 314
, protein 289A
, epithelial glycoprotein